Novel anti-inflammatory agents

Details for Australian Patent Application No. 2010239266 (hide)

Owner Resverlogix Corp.

Inventors Hansen, Henrik C.; Wagner, Gregory S.; Attwell, Sarah C.; McLure, Kevin G.; Kulikowski, Ewelina B.

Agent Cullens

Pub. Number AU-A-2010239266

PCT Pub. Number WO2010/123975

Priority 61/171,620 22.04.09 US

Filing date 21 April 2010

Wipo publication date 28 October 2010

International Classifications

C07D 239/91 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/47 (2006.01) - Quinolines

Event Publications

24 November 2011 PCT application entered the National Phase

  PCT publication WO2010/123975 Priority application(s): WO2010/123975

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010239270-Surgical clamp

2010239265-High-efficiency solar cell structures and methods of manufacture